P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT

Detalles Bibliográficos
Autores principales: C., FEDERICI, E., KUCUKAL, R., KOCEVAR, L., GILKEY, S., SERTEL, K., MONCHAMP, A., WOLFE, L., NAYAK, A., BRUEDERLE, J., ZAK, U., GURKAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426784/
http://dx.doi.org/10.1097/01.HS9.0000873016.07993.e1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426784/
http://dx.doi.org/10.1097/01.HS9.0000873016.07993.e1

Ejemplares similares